Plain-English translation of NCT06368310 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is one of the first times this treatment has been tested in people.
This trial tested a completely new generation of brain electrodes designed to map brain activity during tumor removal surgery. Unlike standard electrodes, these graphene electrodes were extremely thin and flexible, allowing them to follow the brain's surface better and detect electrical signals with greater sensitivity. The study examined whether these new electrodes were safe and practical to use in patients undergoing brain tumor surgery.
Standard brain electrodes used during surgery have limitations—they don't bend well to fit the brain's complex shape, and they need to be large to detect tiny electrical signals. This new treatment was developed to overcome those problems by using graphene, a special carbon material that is more sensitive and allows for smaller, more closely-spaced electrodes that could provide better detail during surgery.
Participants received these new graphene electrodes during their planned brain tumor surgery. The electrodes were placed on or near the brain to map electrical activity and help the surgeon identify important brain regions to protect during tumor removal. The trial evaluated whether the electrodes were safe to use and whether they worked effectively in detecting brain signals during the surgery.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
United Kingdom